Genetron Holdings Limited
GTH · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.09 | -1.68 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -3.32 | -2.05 | -18.66 | -22.51 |
| Quality | ||||
| ROIC | -30.32% | -30.32% | -15.05% | -14.19% |
| Gross Margin | 40.70% | 40.70% | 40.72% | 55.72% |
| Cash Conversion Ratio | -0.15 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 15.30% | 14.86% | 14.69% | 18.15% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.08 | 1.06 | 1.03 | 1.47 |
| Interest Coverage | 0.00 | 0.00 | -2.42 | -184.09 |
| Efficiency | ||||
| Inventory Turnover | 1.44 | 1.44 | 1.48 | 1.14 |
| Cash Conversion Cycle | 177.67 | 177.67 | 283.84 | 305.10 |